Aprea Therapeutics (APRE) Share-based Compensation (2018 - 2026)
Aprea Therapeutics (APRE) recorded Share-based Compensation of $103,193 in Q2 2026, down 24.5% from $136,729 a year earlier but up 2.1% from the prior quarter.
Powered by 
Analysis
Aprea Therapeutics (APRE) Share-based Compensation (2018 - 2026) Analysis & Trends
On a TTM basis, Aprea Therapeutics' Share-based Compensation came in at $427,039 as of Jun 30, 2026, down 19.5% year-over-year; for FY2025, it came in at $478,141, down 2.3% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of -37.4% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $489,436 in FY2024 (+10.1%), $444,459 in FY2023 (-97.4%), $16.98 million in FY2022 (+117.3%) and $7.81 million in FY2021 (+56.8%).
- Quarterly Share-based Compensation has ranged from $16,244 in Q1 2023 to $14.8 million in Q2 2022 over the past five years.
- On a year-over-year basis, Share-based Compensation has declined for four consecutive quarters, with growth averaging 14.5% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 694.3% in Q2 2022, against a decline of 99.2% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $101,068 (Q1 2026), $109,024 (Q4 2025) and $113,754 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Aprea Therapeutics | 40.11 Mn | 40.11 Mn | - | 103,193.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 103,193.00 |
| Mar 31, 2026 | 101,068.00 |
| Dec 31, 2025 | 109,024.00 |
| Sep 30, 2025 | 113,754.00 |
| Jun 30, 2025 | 136,729.00 |
| Mar 31, 2025 | 118,634.00 |
| Dec 31, 2024 | 126,028.00 |
| Sep 30, 2024 | 149,090.00 |
| Jun 30, 2024 | 128,488.00 |
| Mar 31, 2024 | 85,830.00 |
| Dec 31, 2023 | 82,861.00 |
| Sep 30, 2023 | 76,031.00 |
| Jun 30, 2023 | 269,323.00 |
| Mar 31, 2023 | 16,244.00 |
| Dec 31, 2022 | 57,355.00 |
| Sep 30, 2022 | 38,236.00 |
| Jun 30, 2022 | 14.80 Mn |
| Mar 31, 2022 | 2.08 Mn |
| Dec 31, 2021 | 2.09 Mn |
| Sep 30, 2021 | 2.04 Mn |
API Access
Aprea Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=APRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "APRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=APRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();